Treating a GAD65 antibody-associated limbic encephalitis with Basiliximab, a case study

Treating a GAD65 antibody-associated limbic encephalitis with Basiliximab, a case study

Background: Antibodies (ABs) against the 65 kDa isoform of the intracellular enzyme glutamate decarboxylase (GAD65) have been found in limbic encephalitis (LE) and other neurological conditions. The direct significance of anti-GAD65-ABs for epilepsy is unclear. However, in histological preparations...

Full description

Bibliographic Details
Main Authors: Guido eWidman, Kristin eGolombeck, Hubertus eHautzel, Catharina C. Gross, Carlos M Quesada, Juri-Alexander eWitt, Johannes eErmert, Susanne eGreschus, Rainer eSurges, Christoph eHelmstaedter, Heinz eWiendl, Nico eMelzer, Christian E Elger
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-08-01
Series:Frontiers in Neurology
Subjects:
Epilepsy
Limbic Encephalitis
cytotoxic T lymphocytes
GAD65
Basiliximab
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00167/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00167/full

Similar Items